Arginine

Arginine

SCHEMBL27902011

C[N+](C)(C)CC(O)CC(=O)[O-].N=C(N)NCCCC(N)C(=O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACES1PR1S1PR4S1PR5

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SLC22A16 Q86VW1 1/20 0.50
▸ CPT2 P23786 2/20 0.41
▸ CPT1A P50416 2/20 0.41
▸ OTC P00480 1/20 0.40
▸ NOS3 P29474 4/20 0.39
▸ NOS1 P29475 4/20 0.39
▸ NOS2 P35228 4/20 0.39
▸ CPT1B Q92523 1/20 0.38
▸ DDAH1 O94760 1/20 0.38
▸ MAPT P10636 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CRAT P43155 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL27492468 0.99 SLC22A16 (0.49) SLC22A16CPT2CPT1AOTCNOS3
Arginine SCHEMBL1462462 0.94 SLC22A16 (0.44) SLC22A16CPT2CPT1AOTCNOS3
Arginine SCHEMBL22577747 0.94 SLC22A16 (0.44) SLC22A16CPT2CPT1AOTCNOS3
Arginine SCHEMBL28276672 0.93 SLC22A16 (0.43) SLC22A16CPT2CPT1AOTCNOS3
Arginine SCHEMBL15323966 0.92 SLC22A16 (0.43) SLC22A16CPT2CPT1AOTCNOS3
L-Citrulline SCHEMBL25363292 0.90 SLC22A16 (0.53) SLC22A16CPT2CPT1AOTCNOS3
Arginine SCHEMBL7785699 0.86 OTC (0.43) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL5050788 0.86 OTC (0.43) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL15323382 0.84 MAPT (0.39) SLC22A16OTCNOS3NOS1NOS2
Acetylcarnitine SCHEMBL948558 0.84 MEN1 (0.56) CPT2CPT1AOTCNOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102843922-B The neuroprotective of Xiao base Zhi Fang Suan – cognitive decline and/or suppression NITROMEGA CORP. (US) 2015-12-16 — — CN disclosed
CN-102843922-A Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline NITROMEGA CORP 2012-12-26 — — CN disclosed
Send feedback